Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03467373
Title A Study of RO7082859 in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Non-Hodgkin Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

Therapies

Tocilizumab

Cyclophosphamide + Doxorubicin + Obinutuzumab + Prednisone + Vincristine Sulfate

Cyclophosphamide + Doxorubicin + Prednisone + Rituximab + Vincristine Sulfate

RO7082859

Cyclophosphamide + Doxorubicin + Obinutuzumab + Prednisone + RO7082859 + Vincristine Sulfate

Cyclophosphamide + Doxorubicin + Prednisone + Rituximab + RO7082859 + Vincristine Sulfate

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
University of Alabama Medical Center Recruiting Birmingham Alabama 35294 United States Details
Florida Hospital Cancer Inst Withdrawn Orlando Florida 32804 United States Details
Ingalls Memorial Hospital Withdrawn Harvey Illinois 60426 United States Details
Levine Cancer Institute Recruiting Charlotte North Carolina 28204 United States Details
Fox Chase-Temple Cancer Center Recruiting Philadelphia Pennsylvania 19111 United States Details
West Virginia University; Health Sciences Center Completed Morgantown West Virginia 26506 United States Details
Peter Maccallum Cancer Centre Recruiting Melbourne Victoria 3000 Australia Details
Cross Cancer Institute; Clinical Trials Withdrawn Edmonton Alberta T6G 1Z2 Canada Details
Princess Margaret Cancer Center Recruiting Toronto Ontario M5G 1Z5 Canada Details
Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT Recruiting København Ø 2100 Denmark Details
Hopital Claude Huriez; Hematologie Recruiting Lille 59037 France Details
Hopital Hotel Dieu Et Hme; Clinique Hematologie Active, not recruiting Nantes 44093 France Details
Centre Henri Becquerel; Hematologie Recruiting Rouen 76038 France Details
Universitätsklinikum Erlangen, Translational Research Center (TRC), Medizin 5 Recruiting Erlangen 91054 Germany Details
Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie/Onkologie Recruiting Freiburg 79106 Germany Details
Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo. Recruiting Ulm 89081 Germany Details
Universitätsklinikum Würzburg; Studienzentrale Hämatologie/Onkologie Active, not recruiting Würzburg 97080 Germany Details
Istituto Nazionale Tumori Irccs Fondazione g. Pascale;s.c. Ematologia Oncologica Active, not recruiting Napoli Campania 80131 Italy Details
UO Ematologia, Ospedale S.Maria delle Croci Active, not recruiting Ravenna Emilia-Romagna 48121 Italy Details
ASST PAPA GIOVANNI XXIII; Ematologia Recruiting Bergamo Lombardia 24127 Italy Details
Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia Active, not recruiting Rozzano Lombardia 20089 Italy Details
Hospital Universitari Vall d'Hebron; Servicio de Hematologia Recruiting Barcelona 08035 Spain Details
Hospital Clínic i Provincial; Servicio de Hematología y Oncología Active, not recruiting Barcelona 08036 Spain Details
START Madrid-FJD, Hospital Fundacion Jimenez Diaz Recruiting Madrid 28040 Spain Details
The HOPE Clinical Trials Unit Active, not recruiting Leicester LE1 5WW United Kingdom Details
University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility Recruiting London W1T 7HA United Kingdom Details
Nottingham University Hospitals NHS Trust - City Hospital Active, not recruiting Nottingham NG5 1PB United Kingdom Details
Derriford Hospital; Haematology Completed Plymouth PL6 8DH United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field